Courier Therapeutics Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
2
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$510M
- Investors
-
1
Courier Therapeutics General Information
Description
Developer of a therapy platform designed for precise delivery of cytokines to NK and CD8 T cells. The company's technology is based on observations about viral stealth proteins that have evolved over millions of years to target certain receptors with affinity to eliminate target effects of cytokine therapy while increasing efficacy, enabling organizations to activate the immune systems to fight cancer.
Contact Information
Website
www.couriertherapeutics.comCorporate Office
- 3737 Buffalo Speedway
- Suite 1750
- Houston, TX 77098
- United States
Corporate Office
- 3737 Buffalo Speedway
- Suite 1750
- Houston, TX 77098
- United States
Courier Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 28-May-2021 | $510M | Completed | Pre-Clinical Trials | ||
| 5. Early Stage VC | 13-Aug-2018 | Completed | Startup | |||
| 4. Grant | 01-Jan-2018 | Completed | Startup | |||
| 3. Seed Round | 03-Oct-2016 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Aug-2016 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-2015 | Completed | Startup |
Courier Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Courier Therapeutics Comparisons
Industry
Financing
Details
Courier Therapeutics Competitors (78)
One of Courier Therapeutics’s 78 competitors is ImmunOs Therapeutics, a Venture Capital-Backed company based in Schlieren, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ImmunOs Therapeutics | Venture Capital-Backed | Schlieren, Switzerland | ||||
| Arvinas | Formerly VC-backed | New Haven, CT | ||||
| Exo Therapeutics | Venture Capital-Backed | Cambridge, MA | ||||
| RootPath | Venture Capital-Backed | Framingham, MA | ||||
| Plexium | Venture Capital-Backed | San Diego, CA |
Courier Therapeutics Patents
Courier Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021030588-A1 | Orthopoxvirus major histocompatibility complex (mhc) class-i like protein (omcp) for treatment of autoimmune disease | Inactive | 13-Aug-2019 | ||
| GB-202112934-D0 | Bispecific fusion protein using orthopoxvirus major histocompatibility complex (mhc) class 1-like protein (omcp) and tumor-specific binding partner | Active | 18-Feb-2019 | ||
| GB-2596001-A | Bispecific fusion protein using orthopoxvirus major histocompatibility complex (mhc) class 1-like protein (omcp) and tumor-specific binding partner | Active | 18-Feb-2019 | ||
| GB-2596001-A8 | Bispecific fusion protein using orthopoxvirus major histocompatibility complex (mhc) class 1-like protein (omcp) and tumor-specific binding partner | Active | 18-Feb-2019 | ||
| CA-3130582-A1 | Bispecific fusion protein using orthopoxvirus major histocompatibility complex (mhc) class i-like protein (omcp) and tumor-specific binding partner | Pending | 18-Feb-2019 | C07K14/005 |
Courier Therapeutics Signals
Courier Therapeutics Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BioGenerator Ventures | Venture Capital | Minority | ||
| Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | |||
| Mercury Fund | Venture Capital | Minority | ||
| U.S. Department of Health and Human Services | Government |
Courier Therapeutics FAQs
-
When was Courier Therapeutics founded?
Courier Therapeutics was founded in 2015.
-
Where is Courier Therapeutics headquartered?
Courier Therapeutics is headquartered in Houston, TX.
-
What is the size of Courier Therapeutics?
Courier Therapeutics has 2 total employees.
-
What industry is Courier Therapeutics in?
Courier Therapeutics’s primary industry is Drug Discovery.
-
Is Courier Therapeutics a private or public company?
Courier Therapeutics is a Private company.
-
What is the current valuation of Courier Therapeutics?
The current valuation of Courier Therapeutics is .
-
What is Courier Therapeutics’s current revenue?
The current revenue for Courier Therapeutics is .
-
How much funding has Courier Therapeutics raised over time?
Courier Therapeutics has raised $460K.
-
Who are Courier Therapeutics’s investors?
BioGenerator Ventures, Johnson & Johnson Innovation - JLABS, Mercury Fund, and U.S. Department of Health and Human Services have invested in Courier Therapeutics.
-
Who are Courier Therapeutics’s competitors?
ImmunOs Therapeutics, Arvinas, Exo Therapeutics, RootPath, and Plexium are some of the 78 competitors of Courier Therapeutics.
-
When was Courier Therapeutics acquired?
Courier Therapeutics was acquired on 28-May-2021.
-
Who acquired Courier Therapeutics?
Courier Therapeutics was acquired by Valo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process